Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Market Vectors® Pharmaceutical ETF (PPH)

Delayed Data
As of Nov 25
 +0.38 / +0.59%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors  US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for Market Vectors® Pharmaceutical ETF.


1 month+2.37% 3 years+20.67%
3 months-0.48% 5 years--
1 year+1.43% Since inception+18.95%
Data through 11/26/2015

Quote Details

Previous close$64.76
Open day’s range64.83 – 65.31
Net asset value (NAV)65.11 (11/25/2015)
Daily volume16,505
Average volume (3 months)75,530
Data as of 11/25/2015

Peer Comparisonvs. Health ETFs

Performance 5-yr return--+20.45%
Expense Gross exp ratio0.42%0.47%
Risk 5 year sharpe ratio--1.34
Net assets$336.2M$1.7B
Average market cap$83.2B$35.0B
Average P/E20.924.4
Dividend / Share--0.21%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson7.77%
NVS Novartis7.56%
PFE Pfizer5.94%
GSK GlaxoSmithKline5.50%
MRK Merck5.41%
BMY Bristol-Myers Squibb5.35%
AGN Allergan5.29%
SNY Sanofi5.12%
NVO Novo Nordisk4.87%
ABT Abbott Laboratories4.82%